Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home
Telesleep
Diagnostic Validity Study and Cost Analysis of Domiciliary Respiratory
1 other identifier
interventional
320
1 country
1
Brief Summary
The abbreviated diagnostic sleep studies (RP), made at home and transferred telematically to the sleep laboratory, are useful for the diagnosis of sleep apnea and due to a lower cost, it could be an alternative to conventional polysomnography. Objectives: 1) Usefulness of domiciliary study evaluated by percentage of patients diagnosed of SAHS compared with PSG and agreement in the therapeutic decision. 2) Direct costs of patients included in the study. Design: controlled, randomized, crossed and blind (320 patients) comparing PR made at home with PSG, in patients suspicious of SAHS. The equipment transfer will be made by a transport agency from home to home in order to be universal the access to this diagnostic model. The file transmission with the raw data of the study will be made telematically by GPRS. If the aims of the study reach an end there will be a considerable change in the clinical practice making possible the international acceptation of domiciliary PR as diagnosis of SAHS and adapting the diagnosis of this syndrome to the new technologies of communication. The universalization of domiciliary PR would make possible that the diagnosis of SAHS could be done in any patient and in any country with GPRS technology and a transport agency, that is to say in all developed countries. As sleep apneas affect 5-7 million persons in Spain and there is association between sleep apneas and cardiovascular risk, in the immediate future we must evaluate this disease as we do today with the cholesterol determination. If our results are as predicted, the primary care physician could start and in a lot of cases finish the SAHS diagnostic process. This would simplify remarkably the diagnosis of SAHS and would alleviate a lot the process cost all over the world.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 1, 2008
CompletedFirst Posted
Study publicly available on registry
February 14, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedApril 20, 2016
December 1, 2012
9.9 years
February 1, 2008
April 19, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of the two diagnostic models (PR at home and PSG) evaluated by means of percentage of patients who have established the diagnosis of SAHS and agreement in the therapeutic decision.
at the end of the study
Secondary Outcomes (3)
Direct and indirect cost of patients included in the study.
at the end of the study
Relationship cost/efficacy
at the end of study
Number of non valid studies in each group
at the end of study
Study Arms (2)
PR
EXPERIMENTALPSG
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age between 18 and 70 years.
- Without clinical suspicion referred to any other sleep pathology susceptible of presenting daytime sleepiness.
- Living 20 Km or more far from the hospital participating in the study.
You may not qualify if:
- Psychophysical incapacity to answer questionnaires.
- Patients who do not get pass the proof of placing the PR (see below).
- Patients who present restrictive chronic disease previously diagnosed (neoplasy, any origin chronic pain, renal failure, severe chronic obstructive pulmonary disease and any other limited chronic disease)
- Structural cardiopaty or coronary documented non controlled by means of medical treatment .
- Toxicomanies. Alcoholism (more than 80 gr/day in men and 60 gr/day in women.
- Informed consent not obtained.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital San Pedro de Alcántara. Servicio Extremeño de Salud
Cáceres, Caceres, 10003, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan F. Masa, MD
Hospital San Pedro de Alcántara. Cáceres. Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 1, 2008
First Posted
February 14, 2008
Study Start
January 1, 2006
Primary Completion
December 1, 2015
Study Completion
January 1, 2016
Last Updated
April 20, 2016
Record last verified: 2012-12